Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2 USD | +241.30% | +241.30% | +241.30% |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Health Cares and Supplements Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -95.10% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -95.10% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Shuang Liu
CEO | Chief Executive Officer | 46 | 19/08/19 |
Li Yang
BRD | Director/Board Member | 55 | 19/08/19 |
Hua Xie
BRD | Director/Board Member | 54 | 19/08/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Shuang Liu
CEO | Chief Executive Officer | 46 | 19/08/19 |
Hua Xie
BRD | Director/Board Member | 54 | 19/08/19 |
Li Yang
BRD | Director/Board Member | 55 | 19/08/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 99,000,000 | 36,000,000 ( 36.36 %) | 0 | 36.36 % |
Company contact information
Goldenwell Biotech, Inc.
581 Boston Mills Road Suite 300
44236, Hudson
+
Sector
1st Jan change | Capi. | |
---|---|---|
+241.30% | 19.8M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- GWLL Stock
- Company Goldenwell Biotech, Inc.